Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStable
Percentile Rank80
3Y CAGR-17.3%
5Y CAGR+1.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-17.3%/yr
vs +34.3%/yr prior
5Y CAGR
+1.4%/yr
Recent deceleration
Acceleration
-51.6pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.67M | -7.2% |
| 2025 | $5.03M | -49.1% |
| 2024 | $9.88M | +19.6% |
| 2023 | $8.26M | +145.3% |
| 2022 | $3.37M | -22.8% |
| 2021 | $4.36M | -3.1% |
| 2020 | $4.50M | +77.3% |
| 2019 | $2.54M | +60.7% |
| 2018 | $1.58M | -23.0% |
| 2017 | $2.05M | - |